AU2004229159B2 - Medical active agent patch optically less visible on skin - Google Patents
Medical active agent patch optically less visible on skin Download PDFInfo
- Publication number
- AU2004229159B2 AU2004229159B2 AU2004229159A AU2004229159A AU2004229159B2 AU 2004229159 B2 AU2004229159 B2 AU 2004229159B2 AU 2004229159 A AU2004229159 A AU 2004229159A AU 2004229159 A AU2004229159 A AU 2004229159A AU 2004229159 B2 AU2004229159 B2 AU 2004229159B2
- Authority
- AU
- Australia
- Prior art keywords
- active substance
- skin
- patch
- colour
- lightness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000013543 active substance Substances 0.000 title claims abstract description 78
- 239000010410 layer Substances 0.000 claims abstract description 55
- 239000011159 matrix material Substances 0.000 claims abstract description 36
- 239000002356 single layer Substances 0.000 claims abstract description 4
- 239000000049 pigment Substances 0.000 claims description 40
- 239000000975 dye Substances 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 230000003287 optical effect Effects 0.000 claims description 15
- 239000004615 ingredient Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000003860 storage Methods 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 5
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 229960002715 nicotine Drugs 0.000 claims description 4
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 4
- 239000004922 lacquer Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 238000000053 physical method Methods 0.000 claims description 2
- 230000000052 comparative effect Effects 0.000 claims 1
- 235000019646 color tone Nutrition 0.000 description 9
- -1 siloxane, ethylene vinyl Chemical group 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920002799 BoPET Polymers 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000007933 dermal patch Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000012505 colouration Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 229940117958 vinyl acetate Drugs 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 230000004456 color vision Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Spectrometry And Color Measurement (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10317692A DE10317692A1 (de) | 2003-04-17 | 2003-04-17 | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
| DE10317692.6 | 2003-04-17 | ||
| PCT/EP2004/003748 WO2004091590A1 (de) | 2003-04-17 | 2004-04-08 | Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004229159A1 AU2004229159A1 (en) | 2004-10-28 |
| AU2004229159B2 true AU2004229159B2 (en) | 2010-01-28 |
Family
ID=33154271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004229159A Expired AU2004229159B2 (en) | 2003-04-17 | 2004-04-08 | Medical active agent patch optically less visible on skin |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US10653636B2 (enExample) |
| EP (1) | EP1615628B1 (enExample) |
| JP (2) | JP5733875B2 (enExample) |
| KR (1) | KR101052127B1 (enExample) |
| CN (1) | CN100450472C (enExample) |
| AT (1) | ATE415954T1 (enExample) |
| AU (1) | AU2004229159B2 (enExample) |
| BR (1) | BRPI0409889B8 (enExample) |
| CA (1) | CA2522962C (enExample) |
| CY (1) | CY1108832T1 (enExample) |
| DE (2) | DE10317692A1 (enExample) |
| DK (1) | DK1615628T3 (enExample) |
| ES (1) | ES2320550T3 (enExample) |
| IL (1) | IL171399A (enExample) |
| MX (1) | MXPA05010935A (enExample) |
| NZ (1) | NZ543195A (enExample) |
| PL (1) | PL1615628T3 (enExample) |
| PT (1) | PT1615628E (enExample) |
| RU (1) | RU2336866C2 (enExample) |
| SI (1) | SI1615628T1 (enExample) |
| WO (1) | WO2004091590A1 (enExample) |
| ZA (1) | ZA200507034B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10317692A1 (de) * | 2003-04-17 | 2004-11-11 | Lts Lohmann Therapie-Systeme Ag | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
| DE102005010255A1 (de) * | 2005-03-07 | 2006-09-14 | Lts Lohmann Therapie-Systeme Ag | Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung |
| EP1912795B1 (en) * | 2005-08-12 | 2012-02-22 | TCMS Transparent Beauty LLC | System and method for applying a reflectance modifying agent to improve the visual attractiveness of human skin |
| US8942775B2 (en) | 2006-08-14 | 2015-01-27 | Tcms Transparent Beauty Llc | Handheld apparatus and method for the automated application of cosmetics and other substances |
| US8184901B2 (en) | 2007-02-12 | 2012-05-22 | Tcms Transparent Beauty Llc | System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image |
| KR101408488B1 (ko) * | 2006-12-01 | 2014-06-17 | 닛토덴코 가부시키가이샤 | 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법 |
| CN101573115B (zh) * | 2006-12-01 | 2012-06-06 | 日东电工株式会社 | 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法 |
| KR20100015318A (ko) | 2007-02-12 | 2010-02-12 | 릭 비. 예거 | 인간 피부에 정전기적으로 약제를 인가하기 위한 시스템 및 방법 |
| US10092082B2 (en) | 2007-05-29 | 2018-10-09 | Tcms Transparent Beauty Llc | Apparatus and method for the precision application of cosmetics |
| BRPI0912099A2 (pt) * | 2008-05-30 | 2015-10-06 | Eisai R&D Man Co Ltd | preparação percutaneamente absorvível |
| EP2279739B2 (en) * | 2008-05-30 | 2018-02-28 | Nitto Denko Corporation | Donepezil-containing patch preparation and packaging thereof |
| KR20180019198A (ko) * | 2015-06-22 | 2018-02-23 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 피부에 효과를 제공하기 위한 다층 국소-적용 물품 |
| EP3932251A4 (en) * | 2019-02-28 | 2022-03-09 | Panasonic Intellectual Property Management Co., Ltd. | IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD AND FILM |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001078678A1 (en) * | 2000-04-12 | 2001-10-25 | The Procter & Gamble Company | Pre-formed sheet devices suitable for topical application |
| US6361790B1 (en) * | 1994-03-30 | 2002-03-26 | Lectec Corporation | Method of forming adhesive patch for applying medication to the skin |
| WO2002034200A2 (de) * | 2000-10-27 | 2002-05-02 | Lts Lohmann Therapie-Systeme Ag | Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE7529365U (de) | 1976-01-08 | Beiersdorf Ag, 2000 Hamburg | Wund schnell verband | |
| JPS55111416A (en) * | 1979-02-20 | 1980-08-28 | Taisho Pharmaceut Co Ltd | Paster |
| US4594276A (en) * | 1984-04-09 | 1986-06-10 | Minnesota Mining And Manufacturing Company | Printed, removable body tattoos on a translucent substrate |
| JPH0739566B2 (ja) | 1986-02-21 | 1995-05-01 | 積水化学工業株式会社 | 医療用粘着テープもしくはシートの製造方法 |
| US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| US5004510A (en) * | 1989-01-30 | 1991-04-02 | Panzhihua Iron & Steel Co. | Process for manufacturing high strength railroad rails |
| DE4030465C2 (de) * | 1990-09-26 | 1994-06-01 | Ruschke Mona | Pflaster |
| US5120325A (en) * | 1991-06-12 | 1992-06-09 | Fleshtones Products Co., Inc. | Color-matched sterile adhesive bandages containing melanin-like pigment composition |
| CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
| US5264219A (en) * | 1992-08-07 | 1993-11-23 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery backing |
| JPH07206624A (ja) | 1994-01-20 | 1995-08-08 | Shiseido Co Ltd | 皮膚外用剤 |
| DE19519593C1 (de) * | 1995-05-29 | 1996-08-29 | Horstmann Michael | Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung |
| HUP0201299A2 (en) * | 1996-06-20 | 2002-08-28 | Lavipharm Sa | Device for topical treatment of acne and its method of manufacture |
| US6025535A (en) * | 1996-10-28 | 2000-02-15 | The Procter & Gamble Company | Topsheet for absorbent articles exhibiting improved masking properties |
| JPH11116470A (ja) * | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
| DE69941629D1 (de) * | 1998-12-18 | 2009-12-17 | Alza Corp | Durchsichtige transdermale nicotinabgabevorrichtungen |
| DE19912623A1 (de) * | 1999-03-20 | 2000-09-28 | Lohmann Therapie Syst Lts | Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile |
| US8586079B2 (en) * | 2002-06-21 | 2013-11-19 | Graphic Productions Inc. | Promotional simulation for transdermal patch sampler |
| DE10317692A1 (de) * | 2003-04-17 | 2004-11-11 | Lts Lohmann Therapie-Systeme Ag | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
-
2003
- 2003-04-17 DE DE10317692A patent/DE10317692A1/de not_active Withdrawn
-
2004
- 2004-04-08 WO PCT/EP2004/003748 patent/WO2004091590A1/de not_active Ceased
- 2004-04-08 US US10/553,708 patent/US10653636B2/en active Active
- 2004-04-08 PT PT04726478T patent/PT1615628E/pt unknown
- 2004-04-08 CN CNB2004800102813A patent/CN100450472C/zh not_active Expired - Lifetime
- 2004-04-08 SI SI200431046T patent/SI1615628T1/sl unknown
- 2004-04-08 CA CA2522962A patent/CA2522962C/en not_active Expired - Lifetime
- 2004-04-08 EP EP04726478A patent/EP1615628B1/de not_active Expired - Lifetime
- 2004-04-08 AT AT04726478T patent/ATE415954T1/de active
- 2004-04-08 DE DE502004008582T patent/DE502004008582D1/de not_active Expired - Lifetime
- 2004-04-08 MX MXPA05010935A patent/MXPA05010935A/es active IP Right Grant
- 2004-04-08 DK DK04726478T patent/DK1615628T3/da active
- 2004-04-08 ES ES04726478T patent/ES2320550T3/es not_active Expired - Lifetime
- 2004-04-08 NZ NZ543195A patent/NZ543195A/xx not_active IP Right Cessation
- 2004-04-08 JP JP2006505058A patent/JP5733875B2/ja not_active Ceased
- 2004-04-08 PL PL04726478T patent/PL1615628T3/pl unknown
- 2004-04-08 RU RU2005129528/15A patent/RU2336866C2/ru active
- 2004-04-08 BR BRPI0409889A patent/BRPI0409889B8/pt active IP Right Grant
- 2004-04-08 AU AU2004229159A patent/AU2004229159B2/en not_active Expired
- 2004-04-08 KR KR1020057019784A patent/KR101052127B1/ko not_active Expired - Lifetime
-
2005
- 2005-09-02 ZA ZA200507034A patent/ZA200507034B/en unknown
- 2005-10-11 IL IL171399A patent/IL171399A/en not_active IP Right Cessation
-
2009
- 2009-02-27 CY CY20091100230T patent/CY1108832T1/el unknown
-
2011
- 2011-12-26 JP JP2011283480A patent/JP2012092133A/ja active Pending
-
2019
- 2019-02-01 US US16/265,427 patent/US10646453B2/en not_active Expired - Lifetime
-
2020
- 2020-03-11 US US16/815,286 patent/US11426358B2/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361790B1 (en) * | 1994-03-30 | 2002-03-26 | Lectec Corporation | Method of forming adhesive patch for applying medication to the skin |
| WO2001078678A1 (en) * | 2000-04-12 | 2001-10-25 | The Procter & Gamble Company | Pre-formed sheet devices suitable for topical application |
| WO2002034200A2 (de) * | 2000-10-27 | 2002-05-02 | Lts Lohmann Therapie-Systeme Ag | Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11426358B2 (en) | Medical active substance patch with reduced optical conspicuousness on the skin | |
| JP6083734B2 (ja) | リバスチグミンまたはその誘導体を投与するための経皮治療システム | |
| US8663680B2 (en) | Transparent transdermal nicotine delivery devices | |
| AU2006222242B2 (en) | Non-fibrous transdermal therapeutic system and method for its production | |
| JP2002532540A5 (enExample) | ||
| JP2006523637A5 (enExample) | ||
| JP7149951B2 (ja) | ニコチン含有透明経皮吸収治療システム | |
| Jaâfoura et al. | Color Stability of Microhybrid Composite Resins Depending on the Immersion Medium | |
| HK1079455B (en) | Medical active agent patch optically less visible on skin | |
| HK1141982A (en) | Transparent transdermal nicotine delivery devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |